⌘K

Login Start Free

Home/Filings/4/0001822629-24-000012

4//SEC Filing

Lalwani Nikhil 4

Accession 0001822629-24-000012

CIK 0001023024other

View on SEC.gov Company Profile

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 4:44 PM ET

Size

5.1 KB

Accession

0001822629-24-000012

Insider Transaction Report

Form 4

Period: 2024-09-08

ANI PHARMACEUTICALS INCANIP

DirectorPRESIDENT & CEO

Transactions

Tax Payment
Common Stock
2024-09-08$60.51/sh−3,646$220,619→ 373,859 total

Footnotes (1)

[F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,127 shares of restricted stock, the grant of which was previously reported.

Documents

1 file

4
wk-form4_1726001072.xmlPrimary
FORM 4

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001822629

Filing Metadata

Form type: 4
Filed: Sep 9, 8:00 PM ET
Accepted: Sep 10, 4:44 PM ET
Size: 5.1 KB

View on SEC.gov